应用生物工程在组织重建、替代和再生中的应用。
Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.
机构信息
1Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
2Medical Scientist Training Program, Vanderbilt University Medical Center, Nashville, Tennessee.
出版信息
Tissue Eng Part B Rev. 2019 Aug;25(4):259-290. doi: 10.1089/ten.TEB.2018.0325.
Abstract
The use of autologous tissue in the reconstruction of tissue defects has been the gold standard. However, current standards still face many limitations and complications. Improving patient outcomes and quality of life by addressing these barriers remain imperative. This article provides historical perspective, covers the major limitations of current standards of care, and reviews recent advances and future prospects in applied bioengineering in the context of tissue reconstruction, replacement, and regeneration.
摘要
自体组织在组织缺损重建中的应用一直是金标准。然而，目前的标准仍然面临许多限制和并发症。通过解决这些障碍来改善患者的预后和生活质量仍然至关重要。本文提供了历史背景，涵盖了当前护理标准的主要局限性，并回顾了组织重建、替代和再生领域应用生物工程的最新进展和未来前景。
相似文献
1
Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.应用生物工程在组织重建、替代和再生中的应用。
Tissue Eng Part B Rev. 2019 Aug;25(4):259-290. doi: 10.1089/ten.TEB.2018.0325.
2
Liver bioengineering: current status and future perspectives.肝脏生物工程：现状与展望。
World J Gastroenterol. 2012 Dec 21;18(47):6926-34. doi: 10.3748/wjg.v18.i47.6926.
3
Bioengineering skin using mechanisms of regeneration and repair.利用再生和修复机制进行生物工程皮肤构建。
Biomaterials. 2007 Dec;28(34):5100-13. doi: 10.1016/j.biomaterials.2007.07.031. Epub 2007 Aug 3.
4
An overview of the therapeutic potential of regenerative medicine in cutaneous wound healing.再生医学在皮肤伤口愈合中的治疗潜力概述。
Int Wound J. 2017 Jun;14(3):450-459. doi: 10.1111/iwj.12735. Epub 2017 Mar 6.
5
The LOEX perspective on the role of tissue engineering in regenerative medicine.LOEX对组织工程在再生医学中作用的观点。
Biomed Mater Eng. 2006;16(4 Suppl):S19-25.
6
Regenerative medicine in urology.泌尿外科中的再生医学。
Semin Pediatr Surg. 2014 Jun;23(3):106-11. doi: 10.1053/j.sempedsurg.2014.05.002. Epub 2014 May 22.
7
Fibrin as a scaffold for cardiac tissue engineering.纤维蛋白作为心脏组织工程的支架。
Biotechnol Appl Biochem. 2011 Sep-Oct;58(5):301-10. doi: 10.1002/bab.49. Epub 2011 Oct 5.
8
Tissue engineering and biomaterials in regenerative medicine.再生医学中的组织工程与生物材料
Cell Transplant. 2008;17(3):241-3. doi: 10.3727/096368908784153931.
9
Glycomics: New Challenges and Opportunities in Regenerative Medicine.糖组学：再生医学中的新挑战与机遇
Chemistry. 2016 Sep 12;22(38):13380-8. doi: 10.1002/chem.201602156. Epub 2016 Jul 11.
10
Organ bioengineering for the newborn.新生儿器官生物工程
Semin Pediatr Surg. 2014 Oct;23(5):314-23. doi: 10.1053/j.sempedsurg.2014.09.014. Epub 2014 Sep 6.
引用本文的文献
1
Evaluating the immunogenicity of a mouse partial hindlimb for composite allotransplantation.评估小鼠部分后肢复合同种异体移植的免疫原性。
Front Immunol. 2025 Jun 18;16:1595319. doi: 10.3389/fimmu.2025.1595319. eCollection 2025.
2
Advancements in bioengineered and autologous skin grafting techniques for skin reconstruction: a comprehensive review.用于皮肤重建的生物工程和自体皮肤移植技术进展：全面综述
Front Bioeng Biotechnol. 2025 Jan 7;12:1461328. doi: 10.3389/fbioe.2024.1461328. eCollection 2024.
3
Hydrophilic Components as Key Active Ingredients in Adipose-Derived Matrix Bioscaffolds for Inducing Fat Regeneration.亲水性成分作为脂肪源性基质生物支架中诱导脂肪再生的关键活性成分。
Adv Healthc Mater. 2024 Dec;13(31):e2402331. doi: 10.1002/adhm.202402331. Epub 2024 Aug 27.
4
Immunogenicity and tolerance induction in vascularized composite allotransplantation.血管化复合组织同种异体移植中的免疫原性与免疫耐受诱导
Front Transplant. 2024 Feb 13;3:1350546. doi: 10.3389/frtra.2024.1350546. eCollection 2024.
5
Harnessing Bioprinting Technologies for Diabetic Wound Regeneration.利用生物打印技术促进糖尿病伤口再生。
Curr Pharm Biotechnol. 2024 Jun 20. doi: 10.2174/0113892010306310240605050448.
6
Bioengineering of vascularized porcine flaps using perfusion-recellularization.使用灌流再细胞化技术对带血管化猪皮瓣进行生物工程改造。
Sci Rep. 2024 Mar 31;14(1):7590. doi: 10.1038/s41598-024-58095-7.
7
Reconstructive Paradigms: A Problem-Solving Approach in Complex Tissue Defects.重建范例：复杂组织缺损的问题解决方法
J Clin Med. 2024 Mar 17;13(6):1728. doi: 10.3390/jcm13061728.
8
A Comprehensive Review of Evaluating Donor Site Morbidity and Scar Outcomes in Skin Transfer Techniques.皮肤移植技术中供区并发症及瘢痕结局评估的综合综述
Cureus. 2024 Feb 1;16(2):e53433. doi: 10.7759/cureus.53433. eCollection 2024 Feb.
9
Harnessing fine fibers in decellularized adipose-derived matrix for enhanced adipose regeneration.利用脱细胞脂肪来源基质中的细纤维促进脂肪再生。
Mater Today Bio. 2024 Jan 25;25:100974. doi: 10.1016/j.mtbio.2024.100974. eCollection 2024 Apr.
10
Remodelling landscape of tissue-engineered bladder with porcine small intestine submucosa using single-cell RNA sequencing.利用单细胞 RNA 测序技术构建猪小肠黏膜下层组织工程膀胱的重塑景观。
Cell Prolif. 2023 Jan;56(1):e13343. doi: 10.1111/cpr.13343. Epub 2022 Sep 30.
本文引用的文献
1
CRISPR Craft: DNA Editing the Reconstructive Ladder.CRISPR 技术：重建阶梯上的 DNA 编辑。
Plast Reconstr Surg. 2018 Nov;142(5):1355-1364. doi: 10.1097/PRS.0000000000004863.
2
3D biofabrication of vascular networks for tissue regeneration: A report on recent advances.用于组织再生的血管网络的3D生物制造：近期进展报告。
J Pharm Anal. 2018 Oct;8(5):277-296. doi: 10.1016/j.jpha.2018.08.005. Epub 2018 Aug 28.
3
Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.靶向递送至淋巴结的免疫治疗可延长心脏移植物的存活时间。
J Clin Invest. 2018 Nov 1;128(11):4770-4786. doi: 10.1172/JCI120923. Epub 2018 Oct 2.
4
Patisiran: First Global Approval.帕替沙那：全球首次获批。
Drugs. 2018 Oct;78(15):1625-1631. doi: 10.1007/s40265-018-0983-6.
5
Engineering of three-dimensional pre-vascular networks within fibrin hydrogel constructs by microfluidic control over reciprocal cell signaling.通过对相互细胞信号传导的微流体控制在纤维蛋白水凝胶构建物中构建三维预血管网络
Biomicrofluidics. 2018 Jun 20;12(4):042216. doi: 10.1063/1.5027054. eCollection 2018 Jul.
6
The CRISPR tool kit for genome editing and beyond.CRISPR 工具包用于基因组编辑及其他领域。
Nat Commun. 2018 May 15;9(1):1911. doi: 10.1038/s41467-018-04252-2.
7
Extracorporeal Perfusion in Vascularized Composite Allotransplantation: Current Concepts and Future Prospects.血管化复合组织异体移植中的体外灌注：当前概念与未来展望
Ann Plast Surg. 2018 Jun;80(6):669-678. doi: 10.1097/SAP.0000000000001477.
8
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.基于 CRISPR/Cas9 的基因组编辑的非病毒递送系统：挑战与机遇。
Biomaterials. 2018 Jul;171:207-218. doi: 10.1016/j.biomaterials.2018.04.031. Epub 2018 Apr 18.
9
Strategic Design and Fabrication of Nerve Guidance Conduits for Peripheral Nerve Regeneration.神经引导导管的策略设计与制作：用于周围神经再生。
Biotechnol J. 2018 Jul;13(7):e1700635. doi: 10.1002/biot.201700635. Epub 2018 Feb 27.
10
Ethical and Safety Issues of Stem Cell-Based Therapy.基于干细胞的治疗的伦理和安全问题。
Int J Med Sci. 2018 Jan 1;15(1):36-45. doi: 10.7150/ijms.21666. eCollection 2018.
Zotero 插件